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Background: The oligomeric state of -syn in vivo remains unknown.
Results: -syn in the CNS and produced by erythrocytes, mammalian cells, and Escherichia coli exists predominantly as a
disordered monomer.
Conclusion: Native -syn from various sources behaves as unstructured and monomeric.
Significance: Stabilizing monomeric -syn, lowering its levels, and/or inhibiting its fibrillization remain viable therapeutic
strategies for Parkinson disease.
Since the discovery and isolation of -synuclein (-syn) from
human brains, it has been widely accepted that it exists as an
intrinsically disorderedmonomeric protein. Two recent studies
suggested that -syn produced in Escherichia coli or isolated
frommammalian cells and red blood cells exists predominantly
as a tetramer that is rich in-helical structure (Bartels, T., Choi,
J. G., and Selkoe, D. J. (2011) Nature 477, 107–110; Wang, W.,
Perovic, I., Chittuluru, J., Kaganovich, A., Nguyen, L. T. T., Liao,
J., Auclair, J. R., Johnson,D., Landeru, A., Simorellis, A. K., Ju, S.,
Cookson,M. R., Asturias, F. J., Agar, J. N.,Webb, B. N., Kang, C.,
Ringe, D., Petsko, G. A., Pochapsky, T. C., and Hoang, Q. Q.
(2011) Proc. Natl. Acad. Sci. 108, 17797–17802). However, it
remains unknown whether or not this putative tetramer is the
main physiological form of -syn in the brain. In this study, we
investigated the oligomeric state of -syn in mouse, rat, and
human brains. To assess the conformational and oligomeric
state of native -syn in complex mixtures, we generated -syn
standards of known quaternary structure and conformational
properties and compared the behavior of endogenously
expressed -syn to these standards using native and denaturing
gel electrophoresis techniques, size-exclusion chromatography,
and an oligomer-specific ELISA. Our findings demonstrate that
both human and rodent -syn expressed in the central nervous
system exist predominantly as an unfolded monomer. Similar
results were observed when human -syn was expressed in
mouse and rat brains as well as mammalian cell lines (HEK293,
HeLa, and SH-SY5Y). Furthermore, we show that -syn
expressed in E. coli and purified under denaturing or nondena-
turing conditions, whether as a free protein or as a fusion con-
struct with GST, is monomeric and adopts a disordered confor-
mation after GST removal. These results do not rule out the
possibility that-syn becomes structured upon interactionwith
other proteins and/or biological membranes.
-Synuclein (-syn)2 is a 140-residue protein that is highly
expressed in the central nervous system and is the major con-
stituent of Lewy bodies (LBs), the intracellular protein inclu-
sions commonly found in post-mortem human brains of Par-
kinson disease patients (3, 4). Although the precise mechanism
by which LB formation contributes to neurotoxicity and the
loss of dopaminergic neurons are not yet completely under-
stood, strong circumstantial evidence from various sources
(genetics, pathology, cell culture, and transgenic models) sup-
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ports a direct link between the propensity of -syn to undergo
oligomerization and its deleterious effects in the brain
(reviewed in Ref. 5).
Since its discovery and isolation from human brains, it has
been widely accepted that -syn exists as an intrinsically disor-
dered monomeric protein (6, 7). Increased expression (result-
ing from genomic multiplication of the SNCA locus (8, 9)),
missense mutations (A30P, A53T, and E46K (10–12)), oxida-
tive stress (13–16), or increased exposure to heavy metal ions
(17, 18) promotes the misfolding and self-assembly of -syn
into toxic -sheet-rich high molecular weight oligomers and
amyloid fibrils. Therefore, current efforts aimed at targeting
-syn for the treatment of Parkinson disease and related disor-
ders are focused on preventing its misfolding and aggregation
by the following: 1) reducing its expression, 2) promoting its
clearance, and 3) stabilizing themonomeric form of the protein
and/or blocking its assembly into toxic oligomers or fibrils.
A recent study by Bartels et al. (1) suggests that in red blood
cells (RBCs) and mammalian cell lines, -syn exists as a stable
tetramer that is rich in -helical structure and is resistant to
amyloid formation. A subsequent study byWang et al. (2) sug-
gested that -syn expressed in Escherichia coli exists as
dynamic tetramer that is rich in-helical structure. However, it
remains unknown whether or not this putative tetramer is the
main physiological form of -syn in the brain. In this study, we
investigated the oligomeric state of -syn in mouse, rat, and
human brains. To assess the conformational and oligomeric
state of native -syn in complex mixtures, we employed native
and denaturing gel electrophoresis techniques, size-exclusion
chromatography, and oligomer-specific ELISA. Our findings
demonstrate that endogenous and overexpressed -syn in
human, mouse, and rat brains exists predominantly in a mono-
meric state and co-migrates with the unfolded recombinant
monomeric -syn in native gels and gel-filtration columns.
Similarly, endogenous or overexpressed human -syn
expressed in mammalian cell lines (HEK293, HeLa, and
SH-SY5Y) behaved similarly to unfolded monomeric -syn in
all assays performed in this study. These results and the report
by Wang et al. (2) prompted us to reinvestigate the oligomeric
state of recombinant -syn produced in E. coli. Our studies
confirmed previous findings bymultiple groups demonstrating
that -syn expressed in E. coli and purified under denaturing or
nondenaturing conditions, whether expressed alone or as a
fusion with GST, is monomeric and adopts a predominantly
disordered conformation (6, 19, 20). The strength of the work
presented here comes from the convergence of our results, per-
formed independently by a total of seven independent research
groups using multiple methods.
EXPERIMENTAL PROCEDURES
Plasmids—The pT7-7 plasmids were used for the expression
of recombinant human -syn in E. coli. The following two plas-
mids used for the preparation of theGST--syn fusion proteins
pGEX-2TK (in the Lashuel group) and pGEX-4T1 (in the El-
Agnaf group) were kind gifts from the laboratories of Dr. Julia
George (University of Illinois, Urbana-Champaign) and Dr.
Hyangshuk Rhim (The Catholic University College of Medi-
cine, Seoul, Korea), respectively. For the production of AAVs,
human WT -syn, cDNA (GenBankTM accession number
NM_000345) was inserted in the pAAV-PGK-MCS backbone
modified from the pAAV-CMV-MCS plasmid (Stratagene, La
Jolla, CA) using standard cloning procedures. All constructs
were confirmed byDNA sequencing (Microsynth, Switzerland)
using the standard primers provided by the supplier.
Expression and Purification of Recombinant WT Human
-syn Monomers and A140C Disulphide-linked Dimers—
BL21(DE3) cells transformed with a pT7-7 plasmid encoding
WT human -syn were freshly grown on an ampicillin agar
plate; then a single colony was transferred to 50 ml of LB
medium with 100 g/ml ampicillin (AppliChem, Darmstadt,
Germany) and incubated overnight at 37 °C with shaking (pre-
culture). The next day, the pre-culture was used to inoculate
2–4 liters of LB/ampicillin medium. When the A600 of the cul-
tures reached 0.7–0.8, protein expression was induced with 1
mM isopropyl -D-1-thiogalactopyranoside (AppliChem), and
the cells were further incubated at 37 °C for 4 h before harvest-
ing by centrifugation at 5000 rpm in a JLA 8.1000 rotor (Beck-
man Coulter, Bear, CA) for 20min at 4 °C. Lysis was performed
on ice, by resuspending the cell pellet in 40 mM Tris acetate
buffer, pH 8.3, containing 1mM EDTA, 1mM phenylmethylsul-
fonyl fluoride (PMSF), and ultrasonicated (VibraCell VCX130,
Sonics,Newtown,CT)with an output power of 12watts applied
in 30-s pulses followed by a 30-s pause, for a total ultrasonica-
tion time of 5 min. Cell debris were then pelleted by centrifu-
gation at 20,000 rpm in a JA-20 rotor (Beckman Coulter) for 20
min at 4 °C. For the denaturing purification, the supernatant
was then boiled at 100 °C in a water bath for 10min to denature
and precipitate most cellular proteins, which are removed by a
second centrifugation step (JA-20 rotor, 20000 rpm, 4 °C, 20
min). The boiling step was omitted in the native purification
protocol, and the subsequent chromatographic steps were the
same for both methods. Lysates were finally filtered through
0.22-m membranes and applied at 1 ml/min on a HiPrep
16/10 Q FF anion-exchange column connected to an Akta
FPLC system (GE Healthcare) and equilibrated with 20 mM
Tris, pH 8.0. -syn was eluted at 3 ml/min by applying increas-
ing concentrations of up to 1.0 M NaCl in 20 mM Tris, pH 8.0,
using a linear gradient applied over 10 column volumes. -syn
elutes at 300 mM NaCl. -syn-enriched fractions (as deter-
mined by SDS-PAGE/Coomassie Blue analysis) were then
pooled and further purified by gel-filtration chromatography
using a HiLoad 26/60 Superdex 200 column (GE Healthcare)
equilibrated with 50 mM Tris, pH 7.5, 150 mM NaCl. Proteins
were eluted at 2 ml/min; pure fractions were combined and
dialyzed against deionized water at 4 °C using a 7-kDa cutoff
dialysismembrane.-syn purified under denaturing conditions
was then flash-frozen in liquid nitrogen and lyophilized. This
step was omitted with -syn purified under nondenaturing
conditions, and the protein was kept at 4 °C in a liquid state
until use. The A140C mutant was purified similarly to the WT
protein (denaturing protocol). A140C -syn spontaneously
forms disulfide-linked dimers during the course of the
purification.
Expression and Purification of Recombinant GST--syn
Fusion Proteins—Protein expression using E. coli cells trans-
formed with pGEX-2TK--syn and cell lysis were carried out
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under nondenaturing conditions (as described above). The
GST fusion protein was purified from the bacterial lysate by
injection onto a GSTPrep FF 16/10 column at 0.5 ml/min. The
binding buffer for the column was a phosphate-buffered saline
(PBS) solution (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
1.8 mM KH2PO4), pH 7.3, containing 10 mM DTT and 0.1% v/v
Triton X-100. Unbound proteins were washed away with 8 col-
umn volumes (CV) of binding buffer, and then the -syn-GST
fusion protein was eluted with 50mMTris, pH 8.0, 10mMDTT,
10 mM reduced glutathione at 1 ml/min. Fractions containing
-syn were further applied to gel-filtration chromatography
column (HiLoad 26/60 Superdex 200, same conditions as for
the recombinant -syn monomers). Pure fractions were then
subjected to thrombin (GEHealthcare) digestion to remove the
GST tag (10 units of thrombin per mg of fusion protein). The
cleaved GST tag was then removed by loading the crude cleav-
age reaction on aGSTrap FF 5-ml (GEHealthcare) equilibrated
with the same buffer as described above for affinity purification.
The cleaved -syn was collected in the flow-through and dia-
lyzed against 20 mM sodium phosphate, pH 7.4.
GST--synuclein fusion construct in pGEX-4T1 vector was
transformed into E. coli strain BL21(DE3). Protein expression
was performed as described above, except that lysis was per-
formed by six freeze-thaw cycles after resuspending the har-
vested cells in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM
EDTA, 1% Nonidet P-40, 0.1% DTT. Cleared lysates were puri-
fied by glutathione affinity chromatography. Removal of the
GST tag was also performed similarly as described above.
Lysis of Human RBCs—Erythrocyte concentrates (ECs) from
whole blood donations were prepared at the Lausanne Blood
Bank (SRTS VD, Epalinges, Switzerland) according to stan-
dardized procedures. ECs were stored at 4 °C in sodium/ade-
nine/glucose/mannitol solution. ECs that did not satisfy quality
criteria for transfusion were used here. Pelleted RBCs (12 15
ml) were lysed by osmotic shock by addition of 31.7 ml of PBS
0.1 plus protease inhibitor mixture (Roche Applied Science)
and incubated on a roller for 1 h at 4 °C. After lysis reaction, the
supernatantswere separated from insolublematerial by centrif-
ugation at 17,000 g (30 min, 4 °C) and were transferred to six
50-ml tubes. Supernatants were further ultracentrifuged at
100,000 g for 1 h and 30 min at 4 °C, and the obtained super-
natants were filtered with 0.22-m filters to avoid RBC debris
contamination for hemoglobin (Hb) depletion. Supernatants
were saved at 4 °C until Hb depletion.
Hemoglobin Depletion—RBC-soluble extracts were Hb-de-
pleted on nickel-based immobilized metal affinity chromatog-
raphy using a liquid chromatographic BioLogic System from
Bio-Rad, based on themethod developed by Ringrose et al. (21).
Soluble extractswere loaded on anickel-loaded 5-mlHiTrapTM
chelating HP or a 20-ml HisPrepTM FF 16/10 column (GE
Healthcare) using buffer A (PBS 1, 10 mM imidazole) at 1 or 3
ml/min, respectively. The Hb-depleted extract passes directly
through the column, whereas the Hb is retained until elution
with a higher concentration of imidazole. Hb elution was per-
formed by switching the composition of the eluent directly to
100% of buffer B (PBS 1, 100 mM imidazole). Approximately
95 mg of total proteins were loaded on the 5-ml column, and
400–500 mg were loaded on the 20-ml column at each injec-
tion. Hb depletion was quantified according to the Harboe
method (22). Hb-depleted fractions were saved at 4 °C for next
purification steps.
Nondenaturing Purification of-syn fromHumanRBCs—All
steps were performed at 4 °C, in the absence of any detergent or
denaturant. All buffers were filtered (0.65 m) and degassed
before use. The pH of the Hb-depleted RBC extracts (350ml)
was first adjusted to 8.0 before loading at 1 ml/min onto a
HiTrapTM Q HP 5-ml anion-exchange column equilibrated
with 20 mM Tris, 25 mM NaCl, pH 8.0 (ion exchange buffer A).
Unbound proteinswerewashedwith 6CVof IEXbuffer A; then
weakly boundmaterial was removed by applying 5CVof 13% of
IEX buffer B (20mMTris, 1.0 MNaCl, pH 8.0). -syn was eluted
at 1.5 ml/min with a linear gradient from 13 to 100% of ion
exchange buffer B over 12 CV, collecting 1.5-ml fractions that
were analyzed by SDS-PAGE/Western blot (Syn-1 antibody)
and Coomassie staining. -Syn-positive fractions were pooled
for further purification by hydrophobic interaction chromatog-
raphy (HIC). Pooled IEX fractions were diluted to 50 ml with
HIC buffer A (50 mM sodium phosphate, pH 7.0, 1.0 M
(NH4)2SO4), and the final (NH4)2SO4 concentration was
adjusted to 1.0Mwith powder (NH4)2SO4). After filtration (0.22
m), the solution was loaded at 1 ml/min on a HiTrapTM phe-
nyl FF (high substitution) 1-ml HIC column equilibrated with
HIC buffer A. Unbound material was washed with 20 CV of
HIC buffer A, and then proteins were eluted (1.5 ml/min) with
a linear gradient of 0–100% of HIC buffer B (50 mM sodium
phosphate, pH 7.0), during which 750-l fractions were col-
lected. The column was then washed with 10 CV of HIC buffer
B and regenerated with 30 CV of ultra-pure water. Fractions
were analyzed by SDS-PAGE/Western blot (Syn-1 antibody)
and Coomassie staining; -syn-containing fractions were con-
centrated using 5-kDa cutoff Amicon centrifugal concentrators
(Millipore, Zug, Switzerland) and run through a final gel-filtra-
tion chromatography step on a Superdex 200 10/300 GL col-
umn equilibratedwith 50mMTris, pH7.5, 150mMNaCl. 250l
of concentrated HIC fractions were loaded on each gel-filtra-
tion run, and proteins were eluted at 0.5 ml/min while collect-
ing 500-l fractions. Purity was assessed by SDS-PAGE/silver
staining.
Mass Spectrometry—Proteins were analyzed by liquid chro-
matography-mass spectrometry (LC-MS) on either an LCQ
Fleet mass spectrometer or an LTQ system (Thermo Scientific,
San Jose, CA). Prior to MS analysis, protein solutions were
desalted on line by reversed-phase chromatography on either a
Hypersil Gold C18 column (4.6  150 mm, 5 m, Thermo, on
the LCQ Fleet System) or a Poroshell 300SB C3 column (1.0
75 mm, 5 m, Agilent Technologies, Santa Clara, CA, on the
LTQ system). In both cases, 10-l samples were injected on the
column, and the proteins were eluted with a linear gradient
from5 to 95% of solvent B against solvent A, over 10min, where
solvent A was 0.1% formic acid in ultra-pure water, and solvent
B was 0.1% formic acid in acetonitrile. The flow rates were 300
l/min (LCQ Fleet System) and 500 l/min (LTQ System).
Charge state deconvolution was performed with the MagTran
software (Amgen Inc., Thousand Oaks, CA).
NMR Spectroscopy—15N-Labeled recombinant -syn was
obtained from either a denaturing or a nondenaturing purifica-
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tion scheme (7). The next steps were conducted as described
previously (23). Briefly, 1H/15N HSQC data were collected at a
protein concentration of 100 M on a Varian Unity Inova 600-
MHz instrument, processed usingNMRpipe (24), and analyzed
using NMRview (25). Spectra were referenced indirectly to the
NMR standards 4,4-dimethyl-4-silapentane-1-sulfonic acid
and ammonia (26) using the known chemical shift of water.
Circular Dichroism (CD) Spectroscopy—Proteins were dis-
solved in CD buffer (10 mM phosphate buffer, pH 7.4) to the
final concentrations indicated below. CD spectrawere acquired
at 20 °C on a J-815 CD spectrometer (Jasco, Tokyo, Japan) in a
1-mm quartz cuvette. Spectra were recorded in the continuous
scanning mode (50 nm/min) from 195 to 250 nm with a data
pitch of 0.2 nm and a bandwidth of 1 nm. A digital integration
time of 2 s was applied. 10 spectra were averaged and smoothed
with a Savitzky-Golay filter (convolution width, 25 points).
POPG lipid vesicles (100 nm average diameter, prepared by
extrusion) were used at 20 mass eq with respect to -syn for
assessment of membrane binding. Lipid/proteinmixtures were
equilibrated for 30 min at RT before CD spectroscopy.
Analytical Gel Filtration/Static Light Scattering—Samples
were applied at 20 M onto a Superdex 200 10/300 GL column
equilibrated with 50 mM Tris, 150 mM NaCl, 0.05% w/v NaN3,
pH 7.5, and eluted at 0.5 ml/min using an Agilent 1200 series
HPLC pump (Agilent, Santa Clara, CA). Protein detection was
done by monitoring absorbance at 280 nm (Agilent 1200
VWD). Absolute molecular weights were determined by static
light scattering using a Wyatt Dawn Heleos II multiangle light
scattering detector (Wyatt Technology Europe GmbH, Dern-
bach, Germany) connected in series with the UV detector. The
protein concentration data used to obtain molecular weights
from light scattering data were derived from refractive index
measurements (Wyatt Optilab rEX, connected downstream of
the LS detector). The standard value of dn/dc 0.185 ml/g for
proteins was used.
Cell Culture and Transient Transfection—Human embry-
onic kidney cells (HEK293T) andHeLa cells weremaintained in
culture with Dulbecco’s modified Eagle’s medium (DMEM,
Invitrogen) supplemented with 10% fetal bovine serum (FBS)
and 5% penicillin/streptomycin. Human neuroblastoma
SH-SY5Y cells and stably transfected SH-SY5Y-expressing
-synWTwere obtained from SISSA (Neurobiology Sector Ed,
Q1Area Scientific Park, Basovizza; Italy) and cultured inHam’s
F-12minimum Eagle’s medium supplemented with essential
amino acids and 10% FBS. Chinese hamster ovary (CHO) cells
were kindly provided by the Markram laboratory (EPFL, Swit-
zerland). All the media were enriched with 1% penicillin/strep-
tomycin, and the cells were grown in 150-cm2 flasks (TPP,
Trasadingen, Switzerland) in a humidified incubator (5% CO2,
37 °C). The transient transfection of 10g ofDNA inHEK293T
and HeLa cells was performed on 100-mm dishes at a cell den-
sity of 70–80%, using the standard calcium phosphate (CaPO4)
and LipofectamineTM transfection protocols, respectively.
Cell Lysis, Protein Extraction, and Protein Assay—After 72 h
of culture, the cells were harvested and lysed by osmotic shock
in either 20 mM Tris, pH 7.4, or PBS, both containing 1 pro-
tease inhibitor mixture P3840 (Sigma) and 1 mM PMSF and
then passed mechanically through a 0.5  16-mm needle sev-
eral times before sonication (pulse 3 s on and 3 s off, 65%
amplitude). Lysates were then cleared by centrifugation of the
mixture (14,000  g, 15 min, 4 °C), and supernatants were
transferred in new tubes. The total amount of protein in the
total lysate was estimated with the BCATM protein assay kit
from Thermo Scientific, according to the manufacturer’s
instructions.
In-cell Cross-linking—Cells were harvested andwashed twice
with ice-cold 1 PBS, pH 7.4. Disuccinimidyl suberate ligand
(Pierce) was solubilized in DMSO to an initial concentration of
100 mM. The aliquot was then added to the cells to a final con-
centration of 2.5 and 5 mM in a total reaction volume of 100 l.
After a 30-min incubation at room temperature, the reaction
was quenched by addition of 1 M Tris base solution to a final
concentration of 20mM.The cellswere then lysed in 20mMTris
base, pH 7.4, containing 150 mM NaCl, 1 mM EDTA, 0.25%
Nonidet P-40, 0.25% Triton X-100, 1 mM PMSF (Sigma) and
1:200 protease inhibitor mixture (Sigma). Insoluble particles
were pelleted by centrifugation at 14,000 g for 10min at 4 °C.
Native-PAGE—Clear Native-PAGE (CN-PAGE) was per-
formed on 7.5% acrylamide homemade Clear Native-PAGE
(60), with a constant current of 25 mA for 2 h. Briefly, the
resolving gel was obtained bymixing 20% of 40% aqueous acryl-
amide:bisacrylamide (37.5:1) (AppliChem) with 25% of 1.5 M
Tris, pH 8.8, and 56% of double distilled water, and the stacking
gel was prepared by mixing 10% of a 40% aqueous acrylamide:
bisacrylamide (37.5:1) solution, 25% of 0.5 M Tris, pH 6.8, and
65% of double distilled water. Blue Native-PAGE was per-
formed using Novex 4–12% gradient gels. The samples were
prepared by addition of 5% Coomassie G-250 additive. Stan-
dard proteinswere loadedusingNativeMarkUnstainedProtein
Standard (Invitrogen). Blue Native-polyacrylamide gels were
then run at 130 V for 1 h according to the manufacturer’s pro-
tocol. ForWestern blot analysis, proteins were transferred onto
PVDF membranes (0.2 m pore size, Bio-Rad).
Primary Antibodies—The following antibodies were used in
this study: anti-human specific antibody against -syn (Syn-
211 clone), epitope 121–125 (sc-12767), as well as the nonhu-
man specific FL-140, epitope 61–95 (sc-10717) (27), were pur-
chased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
The Syn-1 antibody (epitope 91–99 (28)) was obtained fromBD
Pharmingen. The anti--actin antibody was from Abcam
(Cambridge, MA). The rabbit polyclonal antibody SA-3400
(epitope 117–131, recognizes human and rat -syn) was pur-
chased from Enzo Life Sciences (Farmingdale, NY). Finally, the
goat polyclonal antibody N-19 (recognizes the N-terminal
region of - and -syn) was obtained from Santa Cruz Biotech-
nology, Inc.
SDS-PAGE and Immunoblotting—Samples were diluted in
loading buffer and separated on homogeneous 15% SDS-poly-
acrylamide gels (1.5 mm thickness). The electrophoresis and
Western blot were conducted as described previously (29). For
the detection of endogenous levels of -syn, we employed an
enhanced chemiluminescence (ECL) detectionmethod. Briefly,
PVDF or nitrocellulose membranes were blocked in 5% nonfat
dried milk powder (AppliChem) in PBS for 30 min. The blot
was then incubated overnight at 4 °C with primary antibody
diluted in the antibody solution (5% milk in PBS 0.1% Tween
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20). After four washes with PBS, 0.1% Tween 20 (PBST), the
membrane was incubated for 1 h at room temperature (RT)
with the HRP-conjugated secondary antibody (anti-mouse or
anti-rabbit from The Jackson Laboratory) diluted 1:7500 in
antibody solution. After four washes in PBST and three washes
in PBS, the substrate mixture (SuperSignalWest Pico Chemi-
luminescent Substrate, Pierce) was added to themembrane and
incubated for 5 min at RT. Revelation was then performed by
exposing FUJI medical x-ray films to the substrate-treated
membranes in a dark room.
Immunoassay for-synOligomers—AnELISA 384-well plate
(Nunc Maxisorb, Nunc, Denmark) was coated by overnight
incubation at 4 °C with 1g/ml of mousemonoclonal antibody
(mAb) Syn-211 (Santa Cruz Biotechnology) in 200 mM
NaHCO3, pH 9.6 (50 l/well). Then the plate was washed four
times with PBST and incubated then with 100l/well of block-
ing buffer (5% gelatin from coldwater fish skin, 0.05%Tween 20
in PBS, pH 7.4) for 2 h at 37 °C. After washing four times with
PBST, 50l of the samples to be tested were added in duplicate
and then incubated at 37 °C for another 3 h. Biotinylated Syn-
211 diluted to 1g/ml in blocking buffer was added after wash-
ing with PBST and incubated at 37 °C for 2 h. The plate was
washed and then incubated for 1 h at 37 °C with 50 l/well of
ExtrAvidin-Peroxidase (Sigma). The platewaswashed and then
incubated with 50 l/well of an enhanced chemiluminescent
substrate (Super-Signal ELISA Femto, Pierce), after which
chemiluminescence in relative light units was immediately
measured with a Victor3 1420 (Wallac) microplate reader.
Immunoassay for Total -Synuclein—Total -synuclein lev-
els in different cell lysate samples were measured using a sand-
wichELISA. In brief, the anti-human-synucleinmAbSyn-211
(Santa Cruz Biotechnology) was used for capturing, and the
anti-human -synuclein polyclonal antibody FL-140 (Santa
Cruz Biotechnology) was used for antigen detection through a
horseradish peroxidase (HRP)-linked chemiluminescence
assay. The 384-well ELISA plate (NuncMaxisorb, NUNC,Den-
mark) was coated with 1g/ml Syn-211 (50l/well) in 200mM
NaHCO3, pH 9.6, and incubated overnight at 4 °C. After wash-
ing four timeswith PBS containing 0.05%Tween 20 (PBST) and
incubating for 2 h with 100 l/well of blocking buffer (PBS
containing 5% gelatin and 0.05% Tween 20), 50 l of the cell
lysate samples were then added to each well and incubated at
37 °C for 3 h. Captured -synuclein protein was detected by 0.2
g/ml of FL-140 (50 l/well), followed by incubation with 50
l/well (1:5,000 dilution in blocking buffer) of HRP-labeled
anti-rabbit antibody (The Jackson Laboratory). Bound HRP
activity was assayed by chemiluminescent reaction using an
enhanced chemiluminescent substrate (SuperSignal ELISA
Femto, Pierce). Chemiluminescence in relative light units was
immediatelymeasuredwith aVictor3 1420 (Wallac)microplate
reader. The standard curve for the ELISA was carried out using
50 l/well of recombinant human -synuclein solution at dif-
ferent protein concentrations in blocking buffer.
Preparation of -syn Aggregates—“Aged” -syn samples that
were used in the ELISAswere prepared as follows. 1ml of 50M
purified -syn in PBS, pH 7.4, with few drops of mineral oil on
top was incubated at 37 °C in parafilm-sealed, 1.5-ml Eppen-
dorf tubes for 7 days in a Thermomixer (Eppendorf) with con-
tinuous mixing at 800 rpm.
Extraction of Native -syn from Transgenic Mouse Brains—
Transgenicmice expressingA53Thuman-syn under the con-
trol of the mouse prion protein promoter (kindly provided by
Dr. Michael K. Lee, University of Minnesota) were used in this
analysis to investigate the conformation of the human protein
expressed endogenously in the nervous system. This disease
model demonstrates progressive late-onset neurodegeneration
accompanied by pathological changes and -syn inclusion for-
mation in selective brain regions such as the brainstem,
whereas other regions such as the cortex remain largely unaf-
fected (21). Frontal cortex and brainstem were dissected from
A53T transgenic mice (30) and nontransgenic littermate con-
trol mice at 6 months of age (no apparent motor phenotype at
the time that the mice were sacrificed). Tissues were homoge-
nized briefly with the aid of a mechanical homogenizer in 50
mM HEPES buffer, pH 7.4, containing phosphatase inhibitors,
mixtures 2 and 3 (Sigma), and complete protease inhibitormix-
ture (Roche Applied Science). Following homogenization, the
samples were subjected to ultracentrifugation at 100,000  g
for 20min at 4 °C, and protein concentrationwas determined in
the supernatants by BCA assays (Pierce). The samples were
maintained on ice at all times during preparation, avoiding
freezing and thawing steps. Brains from transgenic mice over-
expressing WT human -syn under the control of the mThy1
promoter that were first described by Rockenstein et al. (31)
were also analyzed. The mThy1--syn transgenic mice were
selected because they display more extensive -syn accumula-
tion in the frontal cortex, limbic system, and subcortical
regions, including the basal ganglia and the substantia nigra
pars compacta (SNpc). Harlan strain C57BL/6JRccHsd (WT)
and C57BL/6JOlaHsd -syn-deficient mice (-synKO) were
obtained from The Jackson Laboratory (ID:003692). For the
immunoblot, a total of 12 6-month-old mice were used (n 4
non-TG; n 4 mThy1--syn TG, and n 4 --syn knock-out
mice).
Recombinant AAV2/6 Production and Titration—Recombi-
nant pseudotyped AAV2/6 vectors were produced, purified,
and titrated as described previously (32). Briefly, we measured
by real time PCR the number of transcriptionally active double-
stranded transgene copies at 48 h in HEK293T cells and
obtained a titer of 7.9  1010 titer units/ml for the AAV2/6-
PGK--syn-WT vector.
Stereotaxic Unilateral Injection into Rat Substantia Nigra
and Tissue Processing—Female adult Sprague-Dawley rats
(Charles River Laboratories, l’Arbresle, France), weighing
200 g, were housed in a 12-h light/dark cycle, with ad libitum
access to food and water, in accordance with Swiss legislation
and the European Community Council directive (86/609/EEC)
for the care and use of laboratory animals. For stereotaxic injec-
tions, the animals were deeply anesthetized with a mixture of
xylazine/ketamine prior to placement in a stereotaxic frame
(David Kopf Instruments, Tujunga, CA). Two l of viral prep-
aration were injected in the right brain hemisphere using a
10-l Hamilton syringe with a 34-gauge blunt tip needle con-
nected to an automatic pump (CMAMicrodialysis, Solna, Swe-
den) at a speed of 0.2l/min. The needle was left in place for an
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additional 7 min before being slowly withdrawn. For transduc-
ing the SNpc, the following coordinates were used: anteropos-
terior, 5.2 mm; mediolateral, 2.0 mm relative to bregma;
dorsoventral, 7.8 mm relative to skull surface. The vector
AAV2/6-PGK--syn-WT was unilaterally injected at a total
dose of 2.8 107 titer units.
Rats were sacrificed by decapitation, and the striatum and
substantia nigra were dissected from both hemispheres and
immediately frozen in liquid nitrogen. For native gel separation,
proteins were extracted using an Ultra-Turrax homogenizer
(Ika, Staufen, Germany) in detergent-free buffer: HEPES 50
mM, pH 7.4, NaCl 150mM, supplementedwith Roche Phospho-
Stop and RocheMini Complete protease inhibitor according to
manufacturer’s instructions (Hoffmann-La Roche). Extraction
volumewas 100l per substantia nigra and 250l per striatum.
Finally, the samples were centrifuged at 200,000 g for 20min,
and the supernatants were collected. All extraction steps were
performed at 4 °C.
Isolation and Characterization of -syn fromHuman Tissues—
A total of 18 human cases were included for this study. These
were divided into three groups as follows: control (neurologi-
cally unimpaired), Alzheimer disease (AD), and dementia with
Lewy bodies (DLB). The autopsy cases in this study came from
patients evaluated at a number of sites associated with the
Alzheimer Disease Research Center at the University of Cali-
fornia, San Diego. Written informed consent for neurobehav-
ioral evaluation, autopsy, and for the collection of samples and
subsequent analysis was obtained from the patient and care-
giver (usually the next of kin) before neuropsychological testing
and after the procedures of the study had been fully explained.
The studymethodologies conformed to the standards set by the
Declaration of Helsinki and Federal guidelines for the protec-
tion of human subjects. All procedures were reviewed and
approved by the University of California, San Diego, Institu-
tional Review Board. The diagnosis of DLB was based in the
initial clinical presentation with dementia followed by parkin-
sonism and the presence of -syn and ubiquitin-positive LBs in
cortical and subcortical regions (33).
As described previously (34), frontal cortex from human and
mouse brain samples (0.1 g) were homogenized in 0.7 ml of
buffer B (1.0 mM HEPES, 5.0 mM benzamidine, 3.0 mM EDTA,
0.5 mM magnesium sulfate, 0.05% sodium azide; final pH 8.8)
containing phosphatase and protease inhibitor mixtures (Cal-
biochem). Samples were centrifuged at 5000  g for 5 min at
room temperature. Supernatants were retained and placed into
appropriate ultracentrifuge tubes and centrifuged at 100,000
g for 1 h at 4 °C. This supernatant was collected to serve as the
cytosolic fraction. The BCA protein assay was used to deter-
mine the protein concentration of the samples.
RESULTS
Although gel electrophoresis and size-exclusion chromatog-
raphy do not allow for accurate determination of protein
molecular weight, especially in the case of natively unfolded
proteins, these techniques remain themost accessible and com-
monly used to estimate the size and oligomeric states of pro-
teins in complex mixtures. In these techniques, the behavior of
proteins is dependent not only on the size but also on the charge
and conformational states (shape) of the protein. Therefore, the
use of globular proteins as calibration standards may not be
appropriate for the characterization of unfolded proteins such
as -syn. To allow more accurate assessment and comparison
of the oligomeric state of -syn derived from different sources,
the following protein standards of well-defined chemical integ-
rity and purity (assessed by SDS-PAGE and mass spectrome-
try), aswell as conformational properties (measured byCD) and
oligomeric state (determined by size-exclusion chromatogra-
phy coupled to light scattering) were generated and used as
controls in all the studies presented below: 1) unfolded mono-
meric -syn from E. coli; 2) disulfide-linked -syn dimer
(A140Cmutation) produced in E. coli; and 3) -syn specifically
acetylated at the N terminus. Unlike -syn produced in E. coli,
the majority of -syn expressed in the brain and in mammalian
cell lines undergoes N-terminal acetylation (35, 36). Direct
comparison of these standards and native -syn from different
sources on the same gel is particularly important, because the
migration profile of a given protein in native gel electrophoresis
is dependent on its molecular weight, conformation and charge
state, as well as the percentage of acrylamide within the gel.
RecombinantWTHuman-syn Produced in E. coli and Puri-
fied under Native or Denaturing Conditions Exists as a Disor-
dered Monomer—Purified recombinant -syn purified from E.
coli is commonly used as a standard and is the main form of
-syn used for all biophysical studies to assess the effect of
mutations, post-translational modifications, protein-ligand
and protein-protein interactions on the biochemical, struc-
tural, and aggregation properties of -syn in vitro. Since the
first observation that -syn is a thermostable protein (37, 38),
most recombinant -syn purification protocols included a
denaturing heating step to remove the majority of heat-labile
cellular proteins, a pre-purification step performed before fur-
ther purification by chromatographic separation techniques
such as ion-exchange and size-exclusion chromatography. In
some cases, a final purification step using reversed-phase chro-
matography is introduced to prepare highly pure protein (23). It
has recently been suggested that these procedures may have
caused the mischaracterization of the native state of -syn (1,
2). Therefore, we first sought to determinewhether this heating
step affects the structure of recombinant-syn purified from E.
coli. As such, bacterial lysates (obtained by gentle ultrasonica-
tion, without the use of any detergent) were either directly fil-
tered through 0.22-m membranes (native, nondenaturing
protocol) or boiled in a water-bath at 100 °C for 10 min and
centrifuged (denaturing protocol). Cleared lysates from both
samples were then purified by anion-exchange followed by gel-
filtration chromatography. Interestingly, -syn from both
denaturing and nondenaturing preparations eluted at the same
volume on the Superdex 200 26/60 gel-filtration column (200
ml), suggesting that both share a similar Stokes radius. Mass
spectrometry (ESI-MS) analysis of both purified native and
denatured -syn showed an identical mass (Fig. 1A). The
deconvoluted masses were 14,457 Da (native protocol) and
14,461 Da (denaturing protocol), which are within the instru-
ment’s measurement error for an expected mass of 14,460 Da.
Purity of these samples was further confirmed by SDS-PAGE,
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which showed that both proteins migrate as single bands with
an apparent mass of19 kDa (Fig. 1B, top panel).
Far-UV CD spectroscopy performed at a protein concentra-
tion of 5 M revealed that both native and heat-treated recom-
binant -syn were mostly devoid of any significant secondary
structure, as shown by a single spectral minimum at195 nm
(Fig. 1C). Moreover, we confirmed that both native and dena-
tured preparations are able to bind lipids and adopt an-helical
structure uponbinding to 100-nmPOPGsmall unilamellar ves-
icles. Because CD spectroscopy only detects quite substantial
conformational changes and is not sensitive to minor differ-
ences in tertiary structure, we further probed the structural
similarity between native and denatured recombinant-syn, by
using the much more sensitive technique of NMR spectros-
copy. 15N-Labeled proteins were obtained from expression in
minimal medium as described previously (23). Denatured
-syn was obtained using a protocol that included reversed-
phase HPLC purification as a last step. It must be noted that for
this sample, the commonly used boiling protocol was not
applied. Denatured-syn was compared with a sample purified
without exposing the protein to any denaturing conditions. As
presented in Fig. 1D, theNMR spectra of-syn obtained for the
two different purification procedures are nearly identical, and
both clearly indicate the highly disordered conformational
ensemble that was originally documented (23) and has since
been extensively studied by us (39–46) and many other groups
(47–53).
We then characterized the quaternary structure of recombi-
nant proteins obtained under both native and denaturing con-
ditions by analytical gel-filtration chromatography/static light
scattering, whichmeasures the absolute weight-averagemolec-
ular mass of proteins. Both native and heat-treated recombi-
nant -syn proteins co-eluted at 14 ml on the Superdex 200
10/300 GL column and showed the same molecular mass of
14  1 kDa (Fig. 1E), which is strongly indicative of a mono-
meric state. The A140C -syn dimeric mutant eluted as two
species as follows: themajor one at12mlwas confirmed to be
dimeric by light scattering (observed molecular mass, 29.6 
0.4 kDa), and a second less abundant species that co-elutedwith
WT recombinant -syn had a measured molecular mass of
14.9 0.7 kDa, consistent with a monomeric state. The system
was correctly calibrated, as shownby the chromatogramof BSA
(measured monomer molecular mass, 62.2  0.1 kDa) for
which dimers and trimers eluting at 11.6 and 10.6 ml,
FIGURE 1.Nondenatured anddenatured recombinantWT-syn exists as anunfoldedmonomer.A, ESI-MS spectra of purified nativeWT-syn (top panel)
and -syn obtained using a boiling protocol (bottom panel). Numbers above the peaks indicate charge states. B, SDS-PAGE (top panel) and CN-PAGE (bottom
panel) analyses of purified recombinant proteins. Lane 1, boiled WT -syn; lane 2, native WT -syn; lane 3, boiled WT -syn (CN-PAGE); lane 4, A140C -syn
(CN-PAGE); lane 5, native WT -syn (CN-PAGE). C, CD spectra of boiled (black) WT -syn and native (red) WT -syn in absence (continuous lines) and presence
(dashed lines) of 100nmof extrudedPOPGsmall unilamellar vesicles (5mass eq.).D, 1H-15NHSQCspectraof denatured (black) versusnative (red)WT 15N-labeled
-syn at 100 M. E, analytical gel filtration/light scattering profiles of boiled (black) versus native (red) -syn. A mixture of A140C -syn monomers and dimers
(blue) and BSA (green) was used as control. Continuous lines correspond to normalized absorbance (280 nm, left ordinate axis), and thin line segments corre-
spond to the calculated molar masses for the corresponding absorbance peaks (right ordinate axis).
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respectively, were also observed with the expected molecular
mass. It is noteworthy that monomeric BSA elutes at a position
very close to monomeric -syn, suggesting a similar Stokes
radius, despite the large difference inmolecularweight between
the two proteins. This observation is consistent with previous
studies demonstrating that unfoldedmonomeric-syn shows a
Stokes radius of 29–34 Å due to its unfolded elongated struc-
ture (6, 44).
It has been suggested that the failure of recombinant-syn to
adopt any stable secondary structure could be due to the
absence of necessary co-factors or machinery needed for its
correct folding in E. coli (1). An alternative explanation would
be that recombinant unfolded -syn represents a kinetically
trapped form of the protein. Therefore, we tried to assess if
overcoming this barrier by using other factors to induce -heli-
cal structure in -syn would lead to the formation of a stable
secondary structure. Toward this, we investigated if mem-
brane-bound -syn would retain its -helical rich structure
after dissociation from the membranes. We hypothesized that
membrane-bound -syn should retain its -helical rich struc-
ture after disassociation from the membrane by addition of a
high salt concentration. After addition of 1 MNaCl, the released
-syn was recovered by filtering the sample through a 100-kDa
cutoff filter. Upon reassessment of the free -syn (flow-
through) conformation by CD, we observed that the protein
had lost its -helical structure and had become unstructured
again (Fig. 2).
Probing the Distribution of -syn Species Using Native Gel
Electrophoresis Techniques—Because native and denaturing gel
electrophoresis remain the primary techniques used to assess
the distribution of quaternary structures of -syn in complex
mixtures from cells or brain tissue lysates, we sought to deter-
mine whether denaturation by boiling would affect the migra-
tion pattern of recombinant or endogenously expressed -syn
on native gels. Interestingly, both native and heat-treated
recombinant -syn co-migrated at an estimated molecular
mass of 66 kDa in clear native gels (homogeneous gel, 7.5%
acrylamide in the resolving section) (Fig. 1B, bottom panel). To
determine to what extent native gels can differentiate between
different sequence and oligomeric variants of -syn, we com-
pared the migration of recombinant: (i) monomeric N-acety-
lated human -syn; (ii) monomeric human and mouse -syn;
(iii)monomeric andphosphorylated-syn at Ser-87 or Ser-129;
and (iv) a disulfide-linked dimeric form of the protein (A140C).
Fig. 3 demonstrates that the disulfide-linked dimeric form of
-syn migrated significantly slower than the WT protein. The
phosphorylated forms of -syn (at Ser-87 or Ser-129) migrated
slightly faster than the WT. Recombinant mouse -syn
migrated at a slightly higher position than the corresponding
human protein. Murine -syn differs from the human protein
by seven residues and has a slightly higher molecular weight
(14,485 Da) than human -syn (14,460 Da). Given the small
difference in mass between the two proteins, it is plausible that
the observed difference in mobility is attributed mainly to the
loss of one negative charge (because of the D121G substitution
in murine -syn) and/or conformational properties of the pro-
teins rather than the small difference in molecular weight.
Importantly, N-terminal acetylation does not significantly
affect the migration of the human protein in native gels, even
though it decreases the net charge of the protein by 1 unit.
Boiling of the samples before loading did not change their elec-
trophoretic mobility (supplemental Fig. S1). These results sug-
gest that native gels could potentially provide a reliable method
for detecting and differentiating between different oligomeric
states andmodified forms of -syn in complex mixtures but do
not provide an accurate estimate of the size and quaternary
structure distribution of -syn.
Native -syn from Mouse and Rat Brains Exhibits Similar,
Properties as the Unfolded Recombinant Monomers—Using
native gels and the well characterized standards described
above, we assessed the quaternary structure distribution of
native -syn expressed in mouse and rat. As such, the electro-
FIGURE 2.Membrane-bound-syn does not keep its-helical conforma-
tion once dissociated. CD spectra were taken without (continuous line) and
with (dashed line) 5 mass eq. of 100 nm of extruded POPG vesicles. Mem-
brane-bound-synwasdissociatedbyaddingNaCl toa final concentrationof
1 M; then vesicles and any remainingmembrane-bound-synwere removed
by filtration through 100-kDa cutoff membranes. The filtrate represents dis-
sociated -syn (dotted line spectrum).
FIGURE 3.Comparisonof electrophoreticmobility of different-synvari-
ants on CN-PAGE. Recombinant proteins were purified as described under
“Experimental Procedures,” and then resolved on a 7.5% clear native gel.
Addition of negative charge at Ser-87 or Ser-129 increases the mobility of
-syn. Unmodified-synmigrates at above 66 kDa.M,-synmonomers;D,-
syn dimers. N-Ac, N-acetylated -syn; M (phospho), phosphorylated -syn
monomer.
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phoretic mobility of endogenous -syn from these samples was
assessed using native and denaturing gel electrophoresis. To
preserve the native conformation of the proteins and to prevent
breakdown of potential higher protein assemblies, the lysis
buffer used to homogenize the tissues was free of detergents
and denaturing agents. Lysates obtained from the cortex and
brainstem regions of 6–7-month-old (pre-symptomatic) A53T
-syn transgenicmice and their nontransgenic littermateswere
loaded on Blue Native 4–12% polyacrylamide gradient gels
along with the protein standards described above. Immuno-
blotting with the -syn-specific antibody Syn-1 (which detects
both human and mouse -syn) revealed that -syn from trans-
genic mouse brain tissues migrates with an apparent molecular
mass of 66 kDa and co-migrates with the unfolded mono-
meric standards (Fig. 4A), but below the dimeric A140C -syn.
The endogenous murine -syn also migrated similarly. SDS-
PAGE showed that all samples (with the exception of A140C
-syn) were monomeric under denaturing conditions (supple-
mental Fig. S2A).
We then tried to perform denaturation assays of native
murine brain-derived -syn by heating the lysates, followed by
resolution on CN-PAGE and Western blot analysis (supple-
mental Fig. S1C). However, heat-induced denaturation resulted
in very broad smearing bands migrating more slowly than the
nonheated samples. The same effect was observed when exog-
enous monomeric (recombinant) -syn was added to brain
homogenates from -syn KO mice before heating, suggesting
that the observed smears are due to co-precipitation of -syn
with other denatured proteins from the lysates.
In addition, we performed similar analyses on brain homo-
genates obtained from rats infected with AAV2/6 vectors driv-
ing the expression ofWT human -syn as described previously
(32). Viral vectors were delivered by stereotaxic injection into
the SNpc, and biochemical analysis was carried out 4 weeks
post-injection. Contralateral (i.e. noninjected) striatum and
SNpc homogenates were included in our analyses as controls to
allow comparison with the overexpressed human -syn. The
total -syn level in the injected hemisphere was higher than in
the noninjected hemisphere, although to a much lower extent
than in transgenic mice (see Fig. 4A), consistent with previous
reports using the samemodel system (54). Interestingly, rat and
overexpressed human -syn in both SNpc and striatum co-mi-
grated again with the same apparent molecular weight as the
unfolded, monomeric standards on Blue Native 4–12% gels
(also at an apparent molecular weight 66 kDa (Fig. 4B)) and
SDS-PAGE (supplemental Fig. S2B). Note that the 20- and
66-kDa bands of the molecular weight standard were not
detected in experiments involving rat and mouse brains,
because Blue Native-PAGE results in the lower parts of the
membrane being stained. Together, these results suggest that
FIGURE 4. Native -syn from in vivo sources co-migrates with recombinant unfolded -syn monomer. A, CN-PAGE analysis of nontransgenic and
transgenic (expressing A53T human -syn) mouse brain homogenates (10g of total protein per lane) extracted under nondenaturing conditions. 200 ng of
recombinant standardswere used. The blotwas probed using the Syn-1 clone antibody that recognizes both human andmouse-syn. Immunodetectionwas
performed using ECL (GE Healthcare) chemiluminescence detection reagent. Images were captured using a FujiFilm LAS-4000 luminescent image analysis
system. ctx, cortex; BS, brain stem. B, same experiment was performed from rat brain homogenates obtained 4 weeks after AAV injection as described under
“Experimental Procedures.” 10 g of total protein were also loaded on each lane. Western blots were processed as in A. SN, substantia nigra; ST, striatum; inj,
injected. C, CN-PAGE of native -syn from human control and diseased brains, an independent mouse transgenic line, and -syn-KO (s-ko) mice (negative
control). For analysis in clear native gels, 18g of total protein (frommouse and human brain homogenates) were prepared in Novex Tris-glycine (Ntg) native
sample buffer (Invitrogen) and separated by gel electrophoresis on 12% Tris-glycine gels (Invitrogen). Blots were incubated overnight at 4 °C with antibodies
against -syn (Millipore). Membranes were processed using a chemiluminescence kit (Western Lightning Chemiluminescence Reagent Plus; PerkinElmer Life
Sciences) and imaged using a Versadoc system (Bio-Rad). The arrow marks nonspecific bands (assigned as such because they appear in -syn-KO mouse
samples). Ctl, control.D, SDS-PAGE analysis of the same samples as in C. Sampleswere heated for 10min at 70 °C and then separated by gel electrophoresis on
4–12% BisTris SDS-polyacrylamide gels (Invitrogen). Western blots were also processed in the same way as in C. IB, immunoblot; N-Ac, N-acetylated -syn.
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-syn from mouse and rat brains exhibit similar apparent size,
charge, and conformational properties as the unfolded mono-
meric recombinant -syn.
As an alternative method to detect potential oligomeric
forms of-syn in rodent brains, we applied wild-type C57BL/6J
mouse brain homogenates (prepared in denaturant-free condi-
tions) onto a Superdex 200 gel-filtration column. The elution
pattern of -syn was then assessed byWestern blotting against
-syn from the collected fractions (supplemental Fig. S3A),
which was compared with the elution of recombinant mono-
meric human -syn alone and to that of recombinant mono-
meric human -syn spiked into brain homogenates obtained
from C57BL/6JRccHsd -syn-KO mice (Harlan, Netherlands)
(supplemental Fig. S3B). As expected, native brain-derived
murine -syn eluted at the same position as the unfolded
recombinant monomer. The same result was obtained when
the recombinant monomer was added into the -syn-KO
mouse brain lysates (supplemental Fig. S3B).
Human -syn from Post-mortem Human Brains and Mono-
meric Unfolded Recombinant Co-migrate on Native and Dena-
turing Gel Electrophoresis—Finally, we wanted to assess the
state of native -syn in post-mortem human brains from
healthy controls, patients with AD, and patients affected with
DLB. Samples were obtained and processed under nondenatur-
ing conditions as described under “Experimental Procedures.”
Immunoblot analysis in SDS-PAGE (Fig. 4D) gels of samples
from human brains showed that -syn is identified in the solu-
ble fractions primarily as a14-kDa protein that appears more
abundant in the brains of the DLB cases compared with con-
trols and AD cases. Then, CN-PAGE was performed. To allow
direct comparison with native -syn, all the samples were
loaded on the same gels. As shown in Fig. 4C, overexpressed
human -syn was detected in the brains of -syn TG mice.
Human brain-derived -syn migrated at50 kDa, at the same
position as the unfolded recombinant protein and -syn from
transgenicmice. The discrepancy between the apparentmolec-
ular weights obtained in this experiment and the others (where
-synmigrated between the 66 and the 146 kDa standards) can
be explained by the different gel systems used (homogeneous
12%here, and homogeneous 7.5% or 4–12% gradient gels in the
other experiments). However, the key observation that native
-syn co-migrates with recombinant monomeric controls
holds in all experiments performed in our studies. Thus, the
dependence of the apparent molecular mass upon the type of
gels used is further evidence that molecular weight estimation
using Native-PAGE is not reliable. Note that endogenous
mouse -syn (from the non-TGmice) migrated slightly slower
than the human protein fromTGmice. This is a property of the
mouse-syn itself, which is also seenwhen recombinantmouse
-syn is run on Native-PAGE (see Fig. 3). These results dem-
onstrate that in native gels (Fig. 4C)-syn fromhuman, rat, and
mouse brains exhibit virtually identical migration and apparent
molecular weight as the unfolded monomeric -syn.
Together, these results suggest that native -syn exists as a
monomer in the brain, which is in contrast to the recent reports
suggesting that native -syn isolated from human red blood
cells, mammalian cell lines, or E. coli exists as a stable tetramer.
To allow direct comparison with previous results, we also
assessed the quaternary structure distribution of-syn in RBCs
andmammalian cell lines (HEK293,HeLa, SH-SY5Y,CHO, and
COS-7 cell lines) relative to the conformationally and hydrody-
namically defined -syn standards described above.
Native -syn from Various Cell Lines Co-migrates with
Recombinant Unfolded Monomers on Native-PAGE and Co-
elute in Size-exclusion Chromatography—We compared the
migration of overexpressed and endogenously expressed -syn
in five differentmammalian cell lines (HEK293T,HeLa, COS-7,
SH-SY5Y, and CHO K1) using denaturing (SDS-PAGE) and
nondenaturing (CN-PAGE) gels. It is noteworthy that endoge-
nous -syn could not be detected using fluorescence detection
(Alexa Fluor-conjugated secondary antibodies) methods (Fig.
5A) but could be observed using enhanced chemiluminescence
upon loading 200 g of total protein lysate (Fig. 5B). Similar to
-syn extracted from mouse, rat, and human brains, native
-syn from HEK, HeLa, and SH-SY5Y cell lines (both endoge-
nous and overexpressed levels) showed similar electrophoretic
mobility as the unfolded monomeric standards on SDS-PAGE
(Fig. 5, A and B) and CN-PAGE (Fig. 5, C and D). No other
(oligomeric) species were observed under these conditions.
Note that -syn obtained from COS-7 cells consistently
migrated at a slightly higher level than expected on CN-PAGE
but always below the dimeric standard. Although the -syn
sequence corresponding to the African green monkey from
which COS-7 cells are derived is not available, the -syn
sequence of the closely related primate Erythrocebus patas sug-
gests a single amino acid substitution (E114Q)within theC-ter-
minal domain of the protein, which shifts the net charge of the
protein by1, which would in turn be expected to slow down
-syn migration on CN-polyacrylamide gels.
These findings were confirmed by size-exclusion chroma-
tography, which showed that native -syn or human -syn
expressed in HEK293T or SH-SY5Y co-elute with the recombi-
nant unfolded -synmonomer in a Superdex 200 column (sup-
plemental Fig. S4A). Furthermore, boiling of native -syn from
SH-SY5Y cells did not change its migration or apparent molec-
ular weight in both native (supplemental Fig. S1B) and denatur-
ing gels (data not shown), suggesting that -syn produced in
these cell lines is devoid of a stable structure and is monomeric.
We also examined SDS-induced denaturation of both recom-
binant proteins and SH-SY5Y cell lysates (supplemental Fig. S1,
A and B, respectively), and found that the negative charge
added upon SDS binding significantly increases the mobility of
the protein on native gels, making this method unsuitable to
assess the effect of SDS-induced denaturation on -syn
migration.
To further characterize the oligomerization of -syn, we
used the oligomer specific ELISA developed by El-Agnaf et al.
(55) (Fig. 6A). To test whether cellular factors present in the cell
lysate could induce oligomerization of exogenous -syn,
recombinant -syn monomer (“fresh”) was also added to the
cell lysates in a parallel experiment. Aggregated (aged) -syn
was added to the cell lysates as positive control. As shown in Fig.
6B, the signals from “endogenous” (red bars) and “exogenous”
(black bars) -syn were similar. Importantly, the signals
obtained from endogenous -syn and exogenous monomeric
-syn were on the same order of magnitude as those observed
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when untransfected cells expressed only very low -syn levels
and remained significantly lower than whenmultimerized (Fig.
6B, aged, white bars) -syn was added to the lysates. These
results suggest that the higher intracellular -syn concentra-
tions resulting from transfection did not result in significant
oligomerization of the protein. As expected, the oligomer-spe-
cific ELISA successfully detected the presence of the 46-kDa
-syn oligomer detected in the RBC sample prepared using the
protocol from Bartels et al. (1) (supplemental Fig. S5D), further
confirming the robustness of this assay to detect small amount
of oligomers.
Protein Cross-linking in Cells—We reasoned that our inabil-
ity to detect stable oligomeric forms of -syn could be
explained by the fact that such oligomers are highly dynamic
and/or unstable. To test this hypothesis, we performed protein
cross-linking using the cell-permeable cross-linker disuccin-
imidyl suberate (spacer arm, 11.4 Å) under the same conditions
recently reported by Bartels et al. (1). When cells overexpress-
ing human-synwere treatedwith disuccinimidyl suberate, we
observed the formation ofmultiple-syn SDS-resistant species
in denaturing PAGE, with the dimer being the predominant
species co-migrating at the same position as our disulfide-
linked A140C -syn dimer (Fig. 7A). Interestingly, in addition
to monomeric and dimeric -syn, small amounts of higher
molecular weight species corresponding to higher order assem-
bly states were also observed. Given that the -syn monomers
and dimers migrate with an apparent molecular mass of 17 and
36 kDa, respectively it is not clear if the band observed at 57
kDa corresponds to -syn trimer or tetramer. We also per-
formed the same cross-linking experiments on untransfected as
well as on stably transfected SH-SY5Yneuroblastoma cells hav-
ing an intermediate level of -syn expression. On SDS-PAGE,
FIGURE5.Recombinantandnative (endogenousandoverexpressed)-synco-migrateas singlemonomeric species.A, SDS-PAGEof cell lysateobtained
from HEK293T and HeLa cells transiently transfected or not (control) with a plasmid encoding WT human -syn. Both recombinant (N-Ac and wt) and
exogenous -syn co-migrate at 15 kDa. The blot was revealed by fluorescence scanned at lower exposure, allowing the detection of exogenous -syn only.
B, SDS-PAGE of five different mammalian cell lines screened for endogenous -syn expression and revealed by enhanced chemiluminescence. Native endog-
enous-syn from these cellswhendetectable co-migrateswith recombinant purified-syn at 15 kDa.C andD, same samples obtained inA and B, respectively,
were resolved in 7.5% CN-PAGE and revealed as described (“Experimental Procedures”). As shown, exogenous -syn WT (C) and native -syn co-migrate as
single band above 66 kDa on CN-PAGE. Endogenous -syn from the COS-7 cell line migrates slightly slower than recombinant -syn and below the recombi-
nant dimers. We failed to detect -syn in CHO cell lysate in both conditions. N-Ac, recombinant purified N-acetylated -syn;Wt, control recombinant purified
-syn; A140C, control recombinant purified dimers;M, -syn monomers; D, -syn dimers.
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the monomer remained the predominant species, and we did
not observe large amounts of cross-linked -syn dimers in
untransfected cells (Fig. 7B). In the case of the stable cell line,
SH-SY5Y, we observed a small amount of dimers and trimers/
tetramers, but the greatmajority of the proteinwasmonomeric.
The highermolecular weight species were alsomuch less abun-
dant in cross-linked samples of untransfected cells and even in
the stably transfected SH-SY5Y cell line expressing moderate
levels of-syn (Fig. 7B, right-most lane). These observations are
consistent with previous cross-linking studies (15, 56–59),
which show predominantly -syn dimers and a distribution of
higher order oligomers.
Purification of Native -syn from Human Erythrocytes—Al-
together, our findings are more consistent with native -syn in
its free form being a predominantly unfolded and monomeric
protein. In all our studies, we failed to detect stable oligomeric
forms of native -syn. Because much of the structural data pre-
sented by Bartels et al. (1) use RBC-derived human -syn, we
investigated the properties of -syn from RBCs and compared
its structure andmigration properties with themonomeric and
dimeric -syn standards.
To characterize human -syn from RBCs, we developed a
purification protocol based on an immobilized metal affinity
chromatography-based Hb depletion that relies on the affinity
of the Hb heme prosthetic groups toward immobilized nickel
ions, prior to -syn purification by three consecutive chroma-
tography steps (ion-exchange 3 HIC 3 SEC) as reported by
Bartels et al. (1), see under “Experimental Procedures” and
“supplemental material.” Note that the second most abundant
protein in RBCs, the 29-kDa carbonic anhydrase-1, is not
depleted by this method. Hb depletion was then quantified by
the Harboe spectrophotometric method (22). Five measure-
ments were carried out, each in triplicate; the calculated
remaining Hb in the depleted fraction was 4.7 0.4%. By using
Western blotting, we established that -syn is present exclu-
sively in the Hb-depleted fraction (supplemental Fig. S6B).
FIGURE 6. Characterization of GST--syn and cell line-derived -syn using an oligomer-specific ELISA. A, schematic depiction of how the same mono-
clonal antibody in both “native” (capture mAb) and biotinylated (detection mAb) versions are used to specifically detect -syn oligomers (right scheme). In this
assay,monomers cannot be detected because the epitope ismasked upon capture (left scheme). Adapted fromEl-Agnaf et al. (55). B,-syn oligomer detection
in cell lysates. The left ordinate axis shows the ELISA readings, and the right ordinate axis displays the total -syn (monomers and oligomers) concentration, in
nontransfected cell lysate, transfected cell lysate, cell lysatemixedwith fresh -syn, or cell lysatemixedwith aged -syn. Themonomeric -syn concentration
(black dots connected with a straight line) were determined by a different sandwich ELISA. M17 Tr., M17 cells transfected with WT human -syn; M17 NTr,
untransfected M17 cells. HeLa and HEK cells were untransfected.
FIGURE 7. In-cell and in vitro cross-linking of-syn. A, in-cell cross-linking of HEK293T cells overexpressing-synWT. Intact cells overexpressing-synwere
harvested, and cross-linking experiments were performed as described under “Experimental Procedures.” Different oligomeric species of -syn resistant to
denaturing conditions are seen in the presence of 2.5 and 5 mM of cross-linker compared with nontreated cells. These higher molecular weight species are
mainly dimers but also traces of trimers/tetramers, as well as high molecular weight oligomers (HMW indicated by a bracket). B, in-cell cross-linking of
untransfected cells. Only the stable SH-SY5Y cells expressing low levels of -syn showed distinct detectable higher molecular weight species of which the
dimers remains the predominant species. Nontransfected cells in contrast showed very little formation of -syn oligomers.M,monomer; D, dimer; T, trimer/
tetramer; IB, immunoblot.
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Probing theHb-depleted lysate with different primary antibod-
ies confirmed the predominance of the full-length protein (Fig.
8A) in addition to a small amount of a truncated form of the
protein. We then assessed the oligomeric state of RBC-derived
-syn in the Hb-depleted lysate by CN-PAGE and Western
blot. -Syn from RBCs co-migrated with recombinantly
expressed WT human -syn, and denaturing it by heating did
not influence its migration in native gels (Fig. 8B), thus suggest-
ing that native -syn from RBCs exists as a heat-stable mono-
meric state with an extended conformation, very similarly to
the bacterially expressed standard. Note that in the Hb-de-
pleted lysate, RBC-derived -syn migrated as three species, the
lowest of which is heat-labile, a property likely that can be
explained by the absence of the C-terminal domain in this spe-
cies, as revealed by Western blotting with the C-terminal-spe-
cific antibody Syn-211 (Fig. 8B, right panel). Further studies are
underway to determine whether the additional species corre-
spond to C-terminal fragments due to proteolysis or corre-
spond to alternative splicing isoforms of -syn as suggested by
Bartels et al. (1). The remaining Hbs, as well as carbonic anhy-
drase-1, were then removed in the anion-exchange chromatog-
raphy step (supplemental Fig. S6C), and the fractions contain-
ing -syn were subjected to further purification by HIC and
size-exclusion chromatography (see supplemental material).
Although this protocol allowed us to obtain highly pure
material, the yield was too low to allow light scattering and
analytical ultracentrifugation analyses. However, we had suffi-
cientmaterial to carry outmass spectrometry andCD spectros-
copy analyses. SDS-PAGE/silver staining of pooled gel-filtra-
tion fractions after concentration showed a purity of  95%
(Fig. 8C), a result confirmed byWestern blotting (Fig. 8D). Elec-
trospray ionization-mass spectrometric analysis (Fig. 8E) of
purified RBC showed a main peak at 14,502 Da, a mass that
exactly matches that of a single acetylation of human -syn.
The mass at 14,519 Da is consistent with a single methionine
oxidation (theoretical mass, 14,518 Da), whereas the peak at
14,686 Da corresponds to the presence of slight amounts of
covalentlymodified-syn by 4-(2-aminoethyl)benzenesulfonyl
fluoride (theoretical mass, 14,685 Da), a commonly used prote-
ase inhibitor which is present in the mixture we used for lysis.
The CD spectrum of RBC-derived -syn exhibited amainmin-
imum around 200 nm, consistent with a predominantly disor-
dered conformation (Fig. 8F), a finding that is consistent with
all other analyses carried out in this study, as well as with pre-
FIGURE 8. Characterization of RBC-derived -syn. A, SDS-PAGE/Western blots of RBC-derived -syn after Hb depletion, probed with two different primary
antibodies as indicatedabove theblots.B,CN-PAGEanalysis of 100ngof RBC-syn fromanHb-depleted lysatewithorwithoutheat-induceddenaturation. The
FL-140 (1:500) and SA3400 (1:2000) primary antibodies were used. Revelation was performed as in A. Boiled samples were heated at 100 °C for 10 min before
loading in the sample wells. The arrow indicates a heat-labile, C-terminally truncated form of -syn. C, characterization of the purified RBC-derived -syn by
SDS-PAGE/silver staining. 1st lane, recombinantWT human-syn control (20 ng). 2nd lane, purified RBC-syn (4l).D, SDS-PAGE/Western blot of the purified
RBC-derived-syn. 20 ng of recombinant-synwere loaded as a control. Western blottingwas done as in A. E, deconvoluted ESI-MS spectrum of purified RBC
-syn, 100 ng of purified RBC-derived -syn were loaded on a Poroshell 300SB C3 column and eluted with increasing concentration of acetonitrile, 0.1%
formic acid. The eluate was analyzed by an LTQ ion trapmass spectrometer. Charge state deconvolution was done usingMagTran. F, CD spectroscopy (1-mm
cell) of pure RBC -syn after its buffer had been exchanged for 20 mM sodium phosphate, pH 7.4. IB, immunoblot.
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viously publishedwork on-syn (6). The presence of a shoulder
at218 nm is characteristic of -syn, although it is more pro-
nounced here.We believe that this signal comes from the pres-
ence of some -syn aggregates resulting from the extensive
concentration steps required to obtain samples that are suitable
for CD measurements. We stress that care should be taken to
prevent the dynode voltage of the CD from saturating in the
190–205 nm wavelength region, as this leads to masking of
random coil signals and the appearance of false-positive CD
signals.
We also attempted to purify human RBC -syn according to
the protocol published by Bartels and co-workers (61). This
experiment was performed on a blood sample from a different
donor. From the three suggested bulk purification techniques
(after pre-purification by differential ammonium sulfate pre-
cipitations, as described (61)), we chose to perform ion-ex-
change chromatography followed by gel filtration, because Hb,
the most prevalent contaminant, should not bind the anion-
exchange column under the conditions described. Purity
assessment by SDS-PAGE/silver staining (supplemental Fig.
S5C) showed the presence of many contaminants, and subse-
quent repurification using HIC failed to produce pure samples
in sufficient amount and purity for conducting detailed bio-
physical studies. Interestingly, SDS-PAGE/Western blotting
analysis of total RBC lysates and anion-exchange chromatogra-
phy fractions revealed the presence of an additional -syn-im-
munoreactive band migrating at 46 kDa, in addition to the
-synmonomer band at14 kDa (supplemental Fig. S5A). The
specificity of this higher molecular band to human -syn was
verified using three different primary antibodies against human
-syn and by immunoprecipitation (supplemental Fig. S5A and
B). Notably, this high molecular weight species is resistant to
boiling, SDS, and reducing agents that are present in the sample
loading buffer, suggesting it may consist of a cross-linked -syn
oligomer or -syn cross-linked to another protein. Proteolytic
digestion followed by tandem mass spectrometry analyses
established the presence of -syn in the 46-kDa complex,
where six unique peptides exclusive to human-synwere iden-
tified (supplemental Fig. S5, E and F), thus further confirming
the immunoblot data. It is important that one does not con-
fuse this46-kDa band with the putative tetramer reported by
Bartels et al. (1) because they did not detect any SDS-stable
oligomers in their samples of -syn purified from RBCs.
Previous studies have suggested that native -syn is sub-
jected to N-terminal acetylation (35, 36). Using tandem mass
spectrometry of GluC-digested samples, we now confirm that
RBC -syn is quantitatively acetylated at its N terminus, thus
establishing that this modification is ubiquitous and not
restricted to -syn in the brain (35, 36).3
Expression of -syn as GST Fusion Followed by Cleavage
Results in Release of Unfolded Monomeric -syn—Recently,
Wang et al. (2) reported that expression of -syn as a GST
fusion protein in E. coli followed by removal of GST results in
-syn that is tetrameric and rich in -helical structure. There-
fore, we attempted to replicate these findings in our laboratory.
In addition, similar studies were carried out independently by
El-Agnaf et al. (55). We used cleavable GST--syn constructs
based on an N-terminal fusion of GST to -syn. The proteins
were purified, and the GST tag was then removed under non-
denaturing conditions as described above. We observed that
-syn after removal of the GST exists predominantly as an
unfolded monomer. Interestingly, we observed that the GST-
-syn fusion protein exists as a mixture of oligomers as dis-
cerned by size-exclusion chromatography and light scattering
(supplemental Fig. S7).We speculated that this oligomerization
is driven by GST itself and not -syn, because the GST used in
pGEX plasmids, originally isolated from the parasite Schisto-
soma japonicum (62), naturally exists as a dimer (see Protein
Data Bank entry 1GNE (63)), as doGST homologs from various
species (64, 65). In support of this hypothesis, we observed very
fast kinetics for the proteolysis of the GST tag by thrombin,
suggesting the cleavage site is very accessible, a situation much
more likely when the -syn domain of the fusion protein is
unfolded and not participating in close intermolecular interac-
tions. Furthermore, the type of the observed GST--syn oligo-
mers depended upon the length of treatment with reducing
agents (short treatments produced a mixture of tetramers and
octamers, longer 20-min treatments with 10 mM DTT pro-
duced a mix of dimers and pentamers, whereas under nonre-
ducing conditions the protein eluted in the void volume of
Superdex 200 and showed a molar mass of 1 MDa). Upon
cleavage of GST, -syn elutes at a position similar to that of the
unfolded monomer. Cleavage and release of -syn was quanti-
tative as seen by SDS-PAGE (Fig. 9A). Furthermore, on CN-
PAGE, the cleaved GST--syn migrated slightly slower than
recombinant WT -syn, most probably due to the 9 additional
residues remaining after cleavage and the presence of two pos-
itively charged residues within this sequence (Fig. 9B). Boiling
the sample did not affect the migration of the cleaved GST--
syn under nondenaturing conditions. If -syn is responsible for
the oligomerization of the uncleaved fusion protein, individual
monomers should be close enough to be cross-linked by BS3, a
water-soluble cross-linking agent with a 11.4-Å spacer length.
The cross-linked -syn oligomers should then be detectable on
SDS-polyacrylamide gels. To determine whether -syn oligo-
merization could be already present in the GST--syn fusion
protein, we treated the protein (1 mg/ml) with 5 mM BS3 for 15
min. After blocking unreacted BS3 with 50mMTris, pH 7.6, the
GST tag was released by treatment with thrombin (RT, 1 h).
The different species were then resolved on SDS-PAGE and
probed byWestern blot against-syn (Fig. 9C). GST--synwas
reduced with 10 mM DTT prior to cross-linking, because we
observed that nonreduced GST forms high molecular weight
species as discussed above. Cross-linking of the fusion protein
(without thrombin treatment, Fig. 9C, 2nd lane) stabilized sev-
eral oligomeric species (bands above the 60-kDamark), includ-
ing dimers and tetramers (although the tetramer band is not
well resolved).When BS3-treated GST--syn was further incu-
bated with thrombin to cleave off the GST tag (Fig. 9C, 4th
lane), we did not observe any low-order oligomeric -syn spe-
cies such as dimer, trimer, or tetramer but instead high molec-
ular weight complexes migrating at100 kDa that may corre-
spond to uncleaved cross-linked GST--syn (in which the3 H. A. Lashuel, unpublished results.
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thrombin cleavage site had been made inaccessible due to
cross-linking). We then performed biophysical studies on the
protein after the GST tag was removed. After GST removal,
-syn eluted at the same position as denatured WT -syn on
gel-filtration column, and measurement of its molecular mass
by static light-scattering showed that the protein exists as a
monomer (Fig. 9D), whichwas also shown to be unfolded byCD
spectroscopy (Fig. 9E).
Similar findings were observed independently by El-Agnaf et
al. (55) using a different GST--syn construct and purification
protocol (described under “Experimental Procedures”). An oli-
gomer-specific ELISA was also employed (see scheme on Fig.
6A), which successfully recognized uncleaved GST--syn as
well as aggregated (aged) -syn (positive control) but not
recombinant denatured -syn nor GST alone (negative con-
trols) (Fig. 10). These data are consistent with our observation
that the GST--syn fusion protein is oligomerized before
removal of the GST tag; however, upon treatment with throm-
bin, the cleaved -syn co-migrated with recombinant -syn
monomer on CN-PAGE (data not shown), thus further sup-
porting the observation that GST is driving the self-association
of the construct.
Altogether, these results further confirm our findings that
-syn expressed in E. coli is monomeric and unfolded and sug-
gest that the GST tag does not stabilize any oligomeric state of
-syn. The results are consistent with the long standing view
that native state of -syn, at least on its own, exists predomi-
nantly in a monomeric disordered conformation.
DISCUSSION
Since its discovery and isolation from human brains, it has
been widely accepted that -syn exists as an intrinsically disor-
dered monomeric protein (6, 7). However, a recent study by
Bartels et al. (1) suggested that physiological -syn exists as a
FIGURE 9. Recombinant purified GST--syn remains an unfolded monomer after removal of the GST tag. A, SDS-PAGE/Coomassie Blue staining of
GST--syn cleavage by thrombin. 2g of proteins were loaded in each lane. Removal of the tag was nearly quantitative after 1 h at RT. B, CN-PAGE analysis of
purified -syn after removal of the GST tag. Purification was performed entirely under nondenaturing conditions as described under “Experimental Proce-
dures.” The lowermobility of cleavedGST--syn is attributable to both the presence of 9 additional residues at its N terminus and the fact that two of them are
positively charged, hence shifting the net charge of the protein. Boiling (100 °C, 10 min) prior to electrophoresis did not change its mobility. C, cross-linking
study of GST--syn. 1mg/ml of reduced (10mMDTT) fusion protein in 20mMphosphate buffer, pH 7.6, was treatedwith 5mMBS3 for 15min at RT (2nd and 4th
lanes) or simply incubated inphosphatebuffer asnegative control (1stand3rd lanes). Then thrombin (10units/mgofGST--syn)was applied to remove theGST
tag (3rd and 4th lanes). Proteins were resolved on 15% SDS-polyacrylamide gels and revealed byWestern blotting (Syn-1, 1:2000, overnight, 4 °C).D, analytical
gel filtration/light scattering analysis of purified cleaved GST--syn. 100 l of protein samples at 20 M were injected and analyzed as indicated under
“Experimental Procedures.” Cleaved GST--syn and denatured recombinant WT -syn co-elute and are monomeric. E, CD spectroscopy was performed at a
protein concentration of 5 M. The spectra shown are averages of 10 runs.M, -syn monomers; D, -syn dimers.
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stable tetramer that is rich in -helical structure and resistant
to amyloid formation. Another study by Wang et al. (2) sug-
gested that -syn produced in E. coli exists as a stable -helical
rich tetramer in the absence of lipid bilayers or micelles. Given
the significant implications of these findings and the fact that
these studies focused primarily on -syn derived from E. coli,
cell lines, and RBCs, we initially sought to reinvestigate the
native state of -syn produced in E. coli and then extended our
studies to assess the oligomeric state of -syn in various mam-
malian cell lines as well as in mouse, rat, and human brains. As
such, we investigated the oligomeric state of -syn in the fol-
lowing: 1) transgenic mice expressing human -syn; 2) rat
brains infected by AAVs encoding WT human -syn; and 3)
human brain (frontal cortex) homogenates from control, AD,
and LBD cases. In all of these studies, protein extraction was
carried out at all times under nondenaturing conditions.
To allow accurate assessment of the oligomeric state of
native -syn and comparison of -syn derived from different
sources, we generated a series of-syn standards ofwell defined
conformational and oligomeric states. These included the fol-
lowing: 1) unfolded monomeric WT -syn; 2) disulfide-linked
-syn dimer (A140Cmutation); and 3) -syn specifically acety-
lated at the N terminus. To ensure reproducibility and to vali-
date results across different laboratories, these standards were
provided to four independent research groups, which are part
of this study, for use as controls in studies aimed at assessing the
oligomeric state of native -syn from different sources. In total,
seven independent groups participated in the work presented
here.
Together, our findings show the following: 1) -syn
expressed in E. coli and purified under denaturing or nondena-
turing conditions is monomeric and adopts disordered confor-
mations; 2) the unfolded -syn monomer co-elutes and co-mi-
grates in native gels and SEC with native -syn (endogenous or
overexpressed) frommammalian cells or isolated under nonde-
naturing conditions, from mouse, rat, and human brains; 3) by
using an oligomer-specific ELISA (55), we failed to detect-syn
oligomers in mammalian cells and cells expressing -syn at
different levels (Fig. 6B); and 4) boiling the native or recombi-
nant unfolded monomer does not affect their migration at an
apparent molecular mass slightly above 66 kDa in clear native
gels. Interestingly, the disulfide-linked dimer (A140C) mi-
grated slower, whereas phosphorylated forms of -syn (Ser(P)-
87, and Ser(P)-129) migrated faster than the unfolded recom-
binant -syn or native -syn. These results suggest that the use
of native gels, although not accurate predictors of molecular
weight of proteins, can still differentiate different oligomeric or
modified forms of -syn. Finally, the co-migration of unfolded
and native -syn suggests that both of these proteins exist as
unfolded monomers (6).
Recombinant -syn Produced in E. coli Exist as Disordered
Monomers—Our results demonstrating that -syn produced in
E. coli is monomeric and unfolded are consistent with previous
studies by Lansbury and co-workers (6), who also demonstrated
that the 66-kDa band in native gels corresponds to unfolded
monomeric -syn. When the migration of -syn in Native-
PAGE was assessed at different acrylamide concentrations and
themolecular weight was extrapolated from the Ferguson plots
(66), they estimated the-syn nativemolecularmass to be 20
3 kDa. Furthermore, sucrose gradient ultracentrifugation stud-
ies by the same group showed that recombinant -syn, purified
under native or denaturing conditions, sediments more slowly
than globular proteins of similar size, consistent with an elon-
gated shape and absence of secondary structure as assessed by
CD and Fourier transform infrared spectroscopy. Moreover,
the measured sedimentation coefficient of 1.7 S, is consistent
with a smaller globular protein of10 kDa. These results have
been confirmed by many other independent groups on -syn
purified under native or denaturing conditions. In particular,
CDmeasurements have always shown that free soluble -syn is
a random coil (43, 44). NMR studies also support the natively
disordered character of -syn; first, 1H/15N-HSQC spectra
showanarrowdispersion of chemical shifts (23, 67).Other lines
of evidence based onNMRalso support an unstructured nature
for -syn; chemical shift values for 13C, 13C, and 1H can be
combined into a single per residue score, which is sensitive to
local secondary structure propensity score (68). Finally, data
from paramagnetic relaxation enhancement is consistent with
a disordered collapsed structure for monomeric -syn where
theN- andC-terminal regions participate in transient intramo-
lecular contacts (44, 46, 69).
Given that the protein used in the studiesWang et al. (2) was
expressed as aGST fusion protein, wewondered if the presence
of GST, which is known to oligomerize, could favor or facilitate
the folding and oligomerization of -syn. To test this hypothe-
sis, we assessed the oligomeric state of a -syn fused to GST
(GST--syn) prior to and after the removal of the GST tag. We
observed that the GST--syn fusion protein exists as an oli-
gomer using two different constructs and independent tech-
niques; one is static light scattering, which showed a small
amount of tetramers and a predominance of octamers, and the
other is an oligomer-specific ELISA developed by El-Agnaf et
al. (55). Such oligomers are most likely initiated by the
dimerization of the GST domain, which is known to occur in
FIGURE 10. Detection of -syn oligomers in vitro using an ELISA-based
assay. Serial dilution shows the specificity of the ELISA to -syn oligomers.
Only aged (aggregated) and cleaved GST--syn and freshly prepared non-
cleaved -syn fused to GST were detectable in a concentration-dependent
manner. The sensitivity of the assay was below 5 nM.
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nature (63–65), but it remains possible that -syn drives the
formation of the higher order oligomers we observed by light
scattering. However, here we demonstrated that the expression
of -syn as a GST fusion does not influence its quaternary
structure and conformational states after removal of GST, i.e.
the protein exists as an unfoldedmonomer. The presence of the
additional nine amino acids (sequence, GSRRASVGS) in -syn
upon cleavage fromGST--syn does not appear to influence its
conformation of an oligomeric state. These findingswere estab-
lished unambiguously through the use of static light scattering
and by the observation that once theGST tag is cleaved, heating
does not affect the migration of the protein on Native-PAGE,
below the dimeric -syn standard (but above the recombinant
WT monomer due to the 10-residue segment remaining after
GST removal).
When studying-syn extracted under nondenaturing condi-
tions from mouse, rat, and human brain homogenates using
CN-PAGE, the protein co-migrated with recombinant mono-
meric -syn, suggesting a similar assembly state for brain-de-
rived -syn. The same studies were conducted on cell lysates
prepared fromboth untransfected and transfected cell lines and
both showed similar results. Using a cell-permeable cross-
linker, we then tried to stabilize putative endogenous -syn
oligomers. In transiently transfected HEK293T cells that
express very high levels of -syn, we detected dimers as the
main -syn oligomeric species. The cross-linking pattern we
observed in transfected HEK293T cells is consistent with the
majority of cross-linking studies of native and recombinant
-syn reported in the literature. The predominance of dimers
within low order oligomers is seen under various conditions,
such as oxidative stress-induced dityrosine cross-linking (15,
70, 71), advanced glycation end product-mediated cross-link-
ing (59), as well as metal ion-induced (57) and Coomassie Bril-
liant Blue-induced cross-linking (56).
Given that our Native-PAGE data show that -syn from cell
lines migrates as a single species, the distribution of cross-
linked -syn species in transfected cells or high concentration
samples in vitromay reflect a cross-linking artifact, resulting in
the observation of diffusion-limited cross-linking reactions of
originally separate monomers. Alternatively, our data may also
reflect the fact that the dimer could be the prevalent -syn
species in cells, suggesting it could serve as the basic building
block for a very complex further assemblymechanism. Because
we did not observe such dimers on Native-PAGE (without
using any cross-linking agent), it is likely that if present under
physiological conditions naturally occurring dimers are highly
dynamic, with an equilibrium largely in favor of the monomer.
Overall, our results combined with extensive studies per-
formed by other groups (6, 50) as well as ours (44) have shown
thatmonomeric unfolded-syn has a Stokes radius of 29–34Å,
which corresponds to an effective molecular mass of58 kDa
for a typical globular protein. The fact that themeasured Stokes
radii at physiological pH values are smaller than expected for a
fully extended random coil was explained by the presence of
transient intramolecular interactions between the N- and
C-terminal regions of -syn (72). Thus, the fact that -syn
migrates with an apparent molecular mass slightly above
66-kDa in native gels and SEC is likely the result of its tendency
to adopt extended conformations and not because it exists in an
oligomeric form, e.g. tetramer. This hypothesis is supported by
the facts that boiling of native -syn from cells and brain tissue
does not change its migration and co-elution with native -syn
from mammalian cells and mouse brain.
The use of well characterized -syn standards of different
sizes and charge states allowed us to assess and test the limita-
tions of native gels and SEC for assessing the distribution of
native-syn in complexmixtures. Although the presence of the
Coomassie dye in BlueNative gels compensates for the effect of
charge, estimation of the protein’s molecular weight still relies
on globular standards. In our study, using both Blue and Clear
Native-PAGE, we confirmed that denatured monomeric -syn
(as assessed by CD and static light scattering) migrates abnor-
mally slowly, as expected from the extended shape conferred by
the disordered state of -syn. Most importantly, we reproduc-
ibly showed that native -syn from brain and cell lines co-mi-
grate with denatured -syn samples, thus strongly supporting
the intrinsically disordered -syn model. The migration of
-syn did not change under denaturing conditions (boiling).
Finally, we used an optimized purification protocol to assess
the oligomeric state of -syn in RBCs (see “Experimental Pro-
cedures” and supplemental figures). Using this protocol, we
obtained native-synwith95% purity as determined by SDS-
PAGE andmass spectrometry (Fig. 8, C andD). The CD results
shown in Fig. 8E demonstrate that native -syn from RBC is
predominantly unstructured. Using Native-PAGE, we estab-
lished that -syn from RBCs migrates at the same position as
the recombinant unfolded -syn, and this migration is not
affected by heat denaturation, consistent with the thermostable
monomeric state and similar to what has been reported for the
recombinant protein (6). Consistent with the observationmade
by Bartels et al. (1), we observed additional bands of lowermass
(see Fig. 8, A and B, and supplemental Fig. S6C), which could
correspond to alternative splicing isoforms or could be a result
of proteolytic processing of-syn. In our case, these bandswere
not present in significant amounts after the final step of purifi-
cation (Fig. 8, C and D).
In a blood sample from a different donor that was purified
using the protocol developed by Bartels et al. (1), we observed a
heat- and SDS-stable -syn-positive band migrating at 46
kDa. However, it is worth noting that Bartels et al. (1) did not
report the detection of any SDS-resistant -syn oligomers in
their denaturing gels. Using Western blotting, oligomer-spe-
cific ELISA, immunoprecipitation, and mass spectrometry, we
confirmed that this additional band corresponds to an oligo-
meric form of -syn. Although not enough material was avail-
able to identify other potentialmembers of this complex (if any)
with confidence, the fact that it is resistant to SDS, heating, and
reducing agents already suggests itmay consist of a cross-linked
-syn oligomer or -syn cross-linked to another protein. A
more systematic study on a larger number of blood donors is
required to determine whether this 46-kDa complex could
have been an artifact or is indeed present in the blood of some
donors but not others.
In conclusion, our findings validate the widely accepted
model of -syn existing physiologically as a natively unfolded
monomer, but it does not rule out the possibility that -syn
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could exist in a folded conformation or as a dynamic oligomer
upon interacting with other proteins, protein complexes,
and/or biological membranes. Although in vitro studies consis-
tently show that -syn adopts -helical conformations upon
binding to synthetic vesicles, very little is known about the con-
formation and oligomeric state of membrane-associated -syn
in neurons. Based on the existing data, we believe that thera-
peutic strategies aimed at stabilizing the monomeric form of
-syn, lowering its levels, and/or inhibiting the process of-syn
fibril formation (73) remain viable strategies for the treatment
of Parkinson disease and related disorders. Finally, our work
stresses the critical importance of using proper standards and
assays to study the oligomeric state of proteinswith an unfolded
character.
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